Zedira
Key Facts
Invested since | 2007 |
Based in | Hesse |
About the company
Zedira is a clinical stage biotech company specialized in the enzyme class of transglutaminases. Zedira performs drug discovery (e.g. celiac disease, diabetic nephropathy and thromboprophylaxis) and markets specialty reagents for R&D and diagnostics.
Zedira in the news
